Model Medicines is transforming drug discovery by leveraging the historical compendium of drug development data and unbiased AI to create Phase II/III ready drug candidates in days rather than decades.

AI/ML

Biotechnology

Pharmaceutical

Model Medicines

Model Medicines' headquarters in San Diego, CA, United States

Daniel Haders II

Sean M. Russell

Patrick Oneill

Rubén Darío Flores Saaib

William Brubaker

Arnab Chatterjee

Tushar Menon

Lani Nguyen

Kris White

Davey Smith

Adolfo Garcia-Sastre

Armen Vidian

Tim Considine

David Garvey

Sumit Chanda

The Advisory Team at Model Medicines provides expert guidance on various facets of drug discovery and development. They leverage their extensive expertise to advise on licensing, preclinical development, scientific strategy, clinical trials, and corporate growth to accelerate the pathway from initial discovery to Phase II/III ready drug candidates.

Advisory Team

The Leadership Team at Model Medicines is responsible for setting the strategic vision and direction of the company, ensuring that innovative approaches to drug discovery are effectively implemented. Comprising the Founders who play key roles as CEO and COO, the team fosters collaboration, drives business development, and oversees operational excellence to accelerate the development of Phase II/III ready drug candidates.

Leadership Team

The Machine Learning Team at Model Medicines focuses on developing and optimizing AI algorithms to analyze extensive drug development data and predict promising drug candidates. By leveraging machine learning models, they expedite the discovery process, enabling the identification of viable Phase II/III ready drug candidates in a fraction of the traditional time.

Machine Learning Team

��

Model Medicines

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Machine Learning Team

Offices

��������

Model Medicines

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Machine Learning Team

Offices

Related companies

��